Last reviewed · How we verify

NCT06146803

the "Level of Resilience" Influencing Self-care in Heart Failure Patients

Status unknown Last updated 23 February 2024
What this trial tests

trial in Congestive Heart Failure in 300 participants. Status unknown.

Timeline
20 November 2023
Primary endpoint
20 November 2024
20 November 2024

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date20 November 2023
Primary completion20 November 2024
Estimated completion20 November 2024
Sites1 location across Italy

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 18 to 90, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adaptation to the new health condition and self-care skills allow people to be able to adhere to the therapeutic treatment in the most correct way possible, but there are many cases in which subjects do not show adherence to it, and for this reason the risk increases to manifest acute complications and also to develop long-term ones

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congestive Heart Failure

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06146803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing